Menu
Recruiting NCT07375069

Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy

— Observational Type 2 Diabetes

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: data collection.
Who it may be relevant to
Registry conditions: Type 2 Diabetes. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy - CardioMET Registry

Overview

CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.

Interventions

  • Other data collection
    Data collection on diabetes therapy and follow-up

Primary outcome measures

  • Diabetes treatment adherence according to the most recent European Guidelines [Time frame: 12-24-36-48 months]

Eligibility criteria

Inclusion criteria

  • Age ≥ 18 years;
  • Diagnosis of type 2 diabetes mellitus (T2DM);
  • Stable clinical conditions
  • Outpatient settings
  • Ability to understand the study procedures and provide written informed consent.

Exclusion criteria

  • Patients with type 1 diabetes mellitus;
  • Active participation in interventional studies;
  • Any condition that may put the patient at risk by participating in the study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Italy · 1 center
  • Federico II University of Naples, Department of Advanced Biomedical Sciences — Naples

Identifiers

NCT: NCT07375069 · Prot. 189/2022

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗